Human Health Division (HHD) Products

Product List by Therapeutic
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Domperidon

Composition:
Vomitop™ Tablet: Each film coated tablet contains Domperidone maleate BP equivalent to 10 mg Domperidone.
Vomitop™ Suspension: Each 5 ml suspension contains Domperidone BP 5 mg.
Vomitop™ Paediatric Drops: Each ml Paediatric drop contains Domperidone BP 5 mg.

Indication:
Prevention & symptomatic relief of acute nausea and vomiting of adults (from any cause specially due to cytotoxic therapy & radiotherapy).Nausea & vomiting associated with L-dopa and bromocriptine treatment for parkinsonian patients. Nausea & vomiting due to migraine, head injury, pancreatitis,gastritis, hepatitis, post-gastrectomy syndrome, haemodialysis and dysmenorrhoea. Non ulcer dyspepsia, oesophageal reflux, reflux oesophagitis & gastritis. Speeding of barium transit in 'follow through' radiological studies.

Dose & Administration:
The recommended dosage for Adult & Elderly patients: 10-20 mg every 4-8 hours.Children: 2-12 years: 0.2-0.4 mg/kg (2-4 ml suspension/10 kg) body weight orally every 4-8 hours. Domperidone should be taken 15-30 minutes before meal. Or as directed by the physician

Esomeprazole

Composition
Esotac20 Capsule: Each delayed release capsule contains Esomeprazole Magnesium Trihydrate USP equivalent to Esomeprazole 20 mg. 
Esotac40 Capsule: Each delayed release capsule contains Esomeprazole Magnesium Trihydrate USP equivalent to Esomeprazole 40 mg. 
Esotac20 Tablet: Each enteric coated tablet contains Esomeprazole Magnesium Trihydrate USP equivalent to Esomeprazole 20 mg. 
Esotac40 Tablet: Each enteric coated tablet contains Esomeprazole Magnesium Trihydrate USP equivalent to Esomeprazole 40 mg. 

Indication
1. Healing of erosive esophagitis
2. Long-term management of esophagitis
3. Symptomatic gastroesophageal reflux disease
4. H. pylori eradication for the treatment of duodenal ulcer (Triple therapy with Esomeprazole, 
clarithromycin and amoxicillin) 

Dose and Administration
Healing of erosive Esophagitis: 20 mg or 40 mg once daily for 4-8 weeks. For those patients who have not healed after 4-8 weeks of treatment, an additional 4-8 weeks course of Esomeprazole may be considered.Long-term management of esophagitis: 20 mg once daily. Symptomatic gastroesophageal reflux disease: 20 mg once daily for 4 weeks.
H. pylori eradication for the treatment of duodenal ulcer (Triple therapy): 20 mg Esomeprazole once daily with 500 mg clarithromycin twice daily and 1g amoxicillin twice daily for 7-10 days or as directed by the physician

Prucalopride

Composition
Prulicon™ 1Tablet: Each film coated tablet contains Prucalopride
Succinate INN equivalent to Prucalopride 1 mg.
Prulicon™2 Tablet: Each film coated tablet contains Prucalopride
Succinate INN equivalent to Prucalopride 2 mg.

Indication
Prulicon™ is indicated for symptomatic treatment of chronic
idiopathic constipation.

Dose & Administration
Take with or without food.
Recommended dosage by patient population:

Hyoscine Hydrobromide

Composition:
Joytrip™150: Each chewable tablet contains Hyoscine
Hydrobromide BP 150 meg.
Joytrip™300: Each tablet contains Hyoscine Hydrobromide BP
300 meg.

Indication:
Prevention and control of nausea and vomiting associated with motion sickness/travel sickness.

Dosage & Administration:
Ideally, take tablets 30 minutes before journey. Adults and
children over 13 years: 300 meg (Maximum 900 meg in 24
hours). Children age 7-12 years: 150-300 meg (Maximum 300
meg in 24 hours). Children age 4-7 years: 150 meg (Maximum
300 meg in 24 hours). Children age 3-4 years: 75 meg
(Maximum 150 meg in 24 hours). Not recommended under 3
years or as directed by the physician.